Gui-Yang Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gui-Yang Jiang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- En-Hua Wang
Department of Pathology, The First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China
2 shared publications - Xiupeng Zhang
China Medical University
2 shared publications - Chuifeng Fan
Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences of China Medical University, 110001, Shenyang, China
1 shared publication - Di Liu
Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences of China Medical University, Shenyang, 110001, China
1 shared publication - Endi Wang
Department of Pathology University of Southern California Keck School of Medicine Los Angeles California USA
1 shared publication - Guang Li
Department of Radiation Oncology, First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China
1 shared publication
Latest Publications
- Open Access
- 24 September 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 704
Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer
Disorders of cell adhesion are critical steps in cancer progression in which varieties of markers including cadherins are involved in.Btbd7 was found to inhibit E-cadherin expression in MDCK cells and play important roles during branching morphogenesis of embryonic salivary glands and lungs. However its function in malignant tumors is largely unknown. The aim of this study is to investigate the clinicopathological significance and possible function of Btbd7 in non-small cell lung cancer. Immunohistochemistry and Western blotting were used to investigate Btbd7 expression in non-small cell lung cancer and lung tissues. The clinicopathological association and the overall survival was analyzed. In vitro experiments were performed using siRNA to investigate the function of Btbd7 in lung cancer cells. Btbd7 expression was elevated in non-small cell lung cancer tissues compared to normal lung tissues. Increased Btbd7 expression was significantly associated with lymph node metastasis, reduced E-cadherin expression and patients’ poor clinical outcome. Downregulation of Btbd7 expression in lung cancer cells by siRNA significantly inhibits cancer cell invasion and effectively restores E-cadherin expression in cancer cell membrane. Btbd7 contributes to reduced expression of E-cadherin and may be a promising cancer marker in non-small cell lung cancer.
- 24 September 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 704
Open AccessBtbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer
Disorders of cell adhesion are critical steps in cancer progression in which varieties of markers including cadherins are involved in.Btbd7 was found to inhibit E-cadherin expression in MDCK cells and play important roles during branching morphogenesis of embryonic salivary glands and lungs. However its function in malignant tumors is largely unknown. The aim of this study is to investigate the clinicopathological significance and possible function of Btbd7 in non-small cell lung cancer. Immunohistochemistry and Western blotting were used to investigate Btbd7 expression in non-small cell lung cancer and lung tissues. The clinicopathological association and the overall survival was analyzed. In vitro experiments were performed using siRNA to investigate the function of Btbd7 in lung cancer cells. Btbd7 expression was elevated in non-small cell lung cancer tissues compared to normal lung tissues. Increased Btbd7 expression was significantly associated with lymph node metastasis, reduced E-cadherin expression and patients’ poor clinical outcome. Downregulation of Btbd7 expression in lung cancer cells by siRNA significantly inhibits cancer cell invasion and effectively restores E-cadherin expression in cancer cell membrane. Btbd7 contributes to reduced expression of E-cadherin and may be a promising cancer marker in non-small cell lung cancer.
- Open Access
- 2 August 2013
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 368
Axin gene methylation status correlates with radiosensitivity of lung cancer cells
We previously reported that Axin1 (Axin) is down-regulated in many cases of lung cancer, and X-ray irradiation increased Axin expression and inhibited lung cancer cells. The mechanisms, however, were not clear.
- 2 August 2013
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 368
Open AccessAxin gene methylation status correlates with radiosensitivity of lung cancer cells
We previously reported that Axin1 (Axin) is down-regulated in many cases of lung cancer, and X-ray irradiation increased Axin expression and inhibited lung cancer cells. The mechanisms, however, were not clear.